Feds Investigate Off-Label ICD Reimbursement
This article was originally published in The Gray Sheet
Executive Summary
Another potentially relevant factor in off-guideline ICD use is whether Medicare is paying for the procedure and whether the payment is appropriate under current coverage policies. The Department of Justice is investigating inappropriate Medicare reimbursement for ICDs, and this study could at minimum provide momentum to that effort, an industry analyst suggests.
You may also be interested in...
Cardiac Rhythm Management Market Faces Continued Challenges Ahead
The CRM market is facing continued growth challenges as manufacturers struggle to jumpstart lagging sales and broaden adoption of implantable cardioverter defibrillators and cardiac resynchronization therapy devices while facing a brewing storm in the US over appropriate device use.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.